Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Bruce H. R. Wolffenbuttel"'
Publikováno v:
Diabetologia, 64(6), 1268-1278. SPRINGER
Diabetologia
Diabetologia
Aims/hypothesis We aimed to assess and contextualise 134 potential risk variables for the development of type 2 diabetes and to determine their applicability in risk prediction. Methods A total of 96,534 people without baseline diabetes (372,007 pers
Autor:
Bianca Silvius, Coen D.A. Stehouwer, Behiye Özcan, M. M. van der Klauw, Petra J. M. Elders, S. van Oort, Marielle A Schroijen, Ingrid M. Jazet, Miranda T. Schram, Bruce H. R. Wolffenbuttel, A. J. van Ballegooijen, Joline W. J. Beulens, Sarah E. Siegelaar, M. F. Warle-van Herwaarden, J. H. DeVries, Femke Rutters, C.J.J. Tack, Cornelis Kramers, H. W. de Valk, Eric J.G. Sijbrands, Evertine J. Abbink
Publikováno v:
Diabetic Medicine, 38(4). WILEY
Diabetic Medicine, 38
van Oort, S, Rutters, F, Warlé-van Herwaarden, M F, Schram, M T, Stehouwer, C D, Tack, C J, Abbink, E J, Wolffenbuttel, B H, van der Klauw, M M, DeVries, J H, Siegelaar, S E, Sijbrands, E J, Özcan, B, de Valk, H W, Silvius, B, Schroijen, M A, Jazet, I M, van Ballegooijen, A J, Beulens, J W J, Elders, P J, Kramers, C & the Diabetes Pearl from the Parelsnoer Initiative 2021, ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ', Diabetic Medicine, vol. 38, no. 4, e14406 . https://doi.org/10.1111/dme.14406
Diabetic Medicine, 38(4):e14406. Wiley-Blackwell Publishing Ltd
Diabetic Medicine, 38, 4
Diabetic Medicine
Diabetic medicine, 38(4):e14406. Wiley-Blackwell
Diabetic Medicine, 38(4):14406. Wiley
Diabetic Medicine, 38(4):e14406. Wiley-Blackwell
Diabetic Medicine, 38(4):e14406. Wiley
Diabetic Medicine, 38
van Oort, S, Rutters, F, Warlé-van Herwaarden, M F, Schram, M T, Stehouwer, C D, Tack, C J, Abbink, E J, Wolffenbuttel, B H, van der Klauw, M M, DeVries, J H, Siegelaar, S E, Sijbrands, E J, Özcan, B, de Valk, H W, Silvius, B, Schroijen, M A, Jazet, I M, van Ballegooijen, A J, Beulens, J W J, Elders, P J, Kramers, C & the Diabetes Pearl from the Parelsnoer Initiative 2021, ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ', Diabetic Medicine, vol. 38, no. 4, e14406 . https://doi.org/10.1111/dme.14406
Diabetic Medicine, 38(4):e14406. Wiley-Blackwell Publishing Ltd
Diabetic Medicine, 38, 4
Diabetic Medicine
Diabetic medicine, 38(4):e14406. Wiley-Blackwell
Diabetic Medicine, 38(4):14406. Wiley
Diabetic Medicine, 38(4):e14406. Wiley-Blackwell
Diabetic Medicine, 38(4):e14406. Wiley
Contains fulltext : 232027.pdf (Publisher’s version ) (Open Access) AIM: To describe the prevalence and characteristics of polypharmacy in a Dutch cohort of individuals with type 2 diabetes. METHODS: We included people with type 2 diabetes from the
Autor:
Henderikus E. Boersma, Melanie M. van der Klauw, Andries J. Smit, Reindert Graaff, Robert P. van Waateringe, Andrew D. Paterson, Bruce H. R. Wolffenbuttel
Publikováno v:
Bmc endocrine disorders, 21(1):14. BMC
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Endocrine Disorders
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Endocrine Disorders
Background Skin autofluorescence (SAF) is a non-invasive marker of tissue accumulation of advanced glycation endproducts (AGE). Recently, we demonstrated in the general population that elevated SAF levels predict the development of type 2 diabetes (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed2dc2625136c460948231e9f0c844c4
https://research.rug.nl/en/publications/3d744748-401c-4ab6-8ad2-e5c2125601f9
https://research.rug.nl/en/publications/3d744748-401c-4ab6-8ad2-e5c2125601f9
Autor:
Eric J.G. Sijbrands, Sanne A.E. Peters, Cees J. Tack, Bruce H. R. Wolffenbuttel, Evertine J. Abbink, Behiye Özcan, Femke Rutters, Marieke J. Oskam, Ingrid M. Jazet, J. Hans DeVries, Miranda T. Schram, Simone J S Sep, Petra J. M. Elders, Sarah E. Siegelaar, Marielle A Schroijen, Coen D.A. Stehouwer, Harold W. de Valk, Marit de Jong
Publikováno v:
BMJ open diabetes research and care, 8(1):e001365. BMJ Publishing Group
de Jong, M, Oskam, M J, Sep, S J S, Ozcan, B, Rutters, F, Sijbrands, E J G, Elders, P J M, Siegelaar, S E, Devries, J H, Tack, C J, Schroijen, M, de Valk, H W, Abbink, E J, Stehouwer, C D A, Jazet, I, Wolffenbuttel, B H R, Peters, S A E & Schram, M T 2020, ' Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: Findings from the Dutch Diabetes Pearl cohort ', BMJ Open Diabetes Research and Care, vol. 8, no. 1, e001365 . https://doi.org/10.1136/bmjdrc-2020-001365
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, 8
Bmj Open Diabetes Research & Care, 8(1):e001365. BMJ Publishing Group
BMJ Open Diabetes Research & Care, 8, 1
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
BMJ Open Diabetes Research & Care, 8(1):001365. BMJ Publishing Group
BMJ Open Diabetes Research and Care, 8(1). BMJ PUBLISHING GROUP
BMJ Open Diabetes Research and Care, 8(1):e001365
BMJ Open Diabetes Research & Care, 8(1):001365. BMJ PUBLISHING GROUP
BMJ Open Diabetes Research and Care
de Jong, M, Oskam, M J, Sep, S J S, Ozcan, B, Rutters, F, Sijbrands, E J G, Elders, P J M, Siegelaar, S E, Devries, J H, Tack, C J, Schroijen, M, de Valk, H W, Abbink, E J, Stehouwer, C D A, Jazet, I, Wolffenbuttel, B H R, Peters, S A E & Schram, M T 2020, ' Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: Findings from the Dutch Diabetes Pearl cohort ', BMJ Open Diabetes Research and Care, vol. 8, no. 1, e001365 . https://doi.org/10.1136/bmjdrc-2020-001365
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, 8
Bmj Open Diabetes Research & Care, 8(1):e001365. BMJ Publishing Group
BMJ Open Diabetes Research & Care, 8, 1
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
BMJ Open Diabetes Research & Care, 8(1):001365. BMJ Publishing Group
BMJ Open Diabetes Research and Care, 8(1). BMJ PUBLISHING GROUP
BMJ Open Diabetes Research and Care, 8(1):e001365
BMJ Open Diabetes Research & Care, 8(1):001365. BMJ PUBLISHING GROUP
BMJ Open Diabetes Research and Care
IntroductionSex differences in cardiometabolic risk factors and their management in type 2 diabetes (T2D) have not been fully identified. Therefore, we aimed to examine differences in cardiometabolic risk factor levels, pharmacological treatment and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4129805fe571b999cf45bc0669c74286
https://pure.amc.nl/en/publications/sex-differences-in-cardiometabolic-risk-factors-pharmacological-treatment-and-risk-factor-control-in-type-2-diabetes-findings-from-the-dutch-diabetes-pearl-cohort(5ce08b5e-f6e4-4ad2-af5f-acfb7718896a).html
https://pure.amc.nl/en/publications/sex-differences-in-cardiometabolic-risk-factors-pharmacological-treatment-and-risk-factor-control-in-type-2-diabetes-findings-from-the-dutch-diabetes-pearl-cohort(5ce08b5e-f6e4-4ad2-af5f-acfb7718896a).html
Autor:
Fumiaki Imamura, George Davey Smith, Chanwook Lee, Nicholas J. Wareham, M. Arfan Ikram, George McMahon, Aysu Okbay, Frank J. A. van Rooij, Peter Bowers, Carson C. Chow, Patrick Turley, Ronald de Vlaming, Jian'an Luan, Oscar H. Franco, Trudy Voortman, Daniel J. Benjamin, André G. Uitterlinden, Casper A.P. Burik, Nita G. Forouhi, K. Paige Harden, Pauline M Emmett, Cornelius A. Rietveld, Juan R. González, Bruce H. R. Wolffenbuttel, Philipp Koellinger, Mark Alan Fontana, James J. Lee, David Cesarini, Harold Snieder, Kim Valeska Emilie Braun, Emma L Anderson, Jana V. van Vliet-Ostaptchouk, Peter J. van der Most, Richard Karlsson Linnér, Susan M. Ring, Claudia Langenberg, Tonũ Esko, Fernando Rivadeneira, Kaitlin H Wade, Jessica C. Kiefte-de Jong, Taulant Muka, Mohsen Ghanbari, S. Fleur W. Meddens
Publikováno v:
Molecular Psychiatry, 26, 2056-2069. NATURE PUBLISHING GROUP
the 23 and Me Research Team 2020, ' Genomic analysis of diet composition finds novel loci and associations with health and lifestyle ', Molecular Psychiatry, vol. 2020 . https://doi.org/10.1038/s41380-020-0697-5
Molecular Psychiatry. Nature Publishing Group
Molecular Psychiatry
23Andme Research Team, EPIC-InterAct Consortium & LifeLines Cohort Study 2020, ' Genomic analysis of diet composition finds novel loci and associations with health and lifestyle ', Molecular Psychiatry, vol. 26, no. 6, pp. 2056-2069 . https://doi.org/10.1038/s41380-020-0697-5
Molecular psychiatry, vol 26, iss 6
Molecular Psychiatry, 26. Nature Publishing Group
Molecular Psychiatry, 26(6), 2056-2069. Nature Publishing Group
the 23 and Me Research Team 2020, ' Genomic analysis of diet composition finds novel loci and associations with health and lifestyle ', Molecular Psychiatry, vol. 2020 . https://doi.org/10.1038/s41380-020-0697-5
Molecular Psychiatry. Nature Publishing Group
Molecular Psychiatry
23Andme Research Team, EPIC-InterAct Consortium & LifeLines Cohort Study 2020, ' Genomic analysis of diet composition finds novel loci and associations with health and lifestyle ', Molecular Psychiatry, vol. 26, no. 6, pp. 2056-2069 . https://doi.org/10.1038/s41380-020-0697-5
Molecular psychiatry, vol 26, iss 6
Molecular Psychiatry, 26. Nature Publishing Group
Molecular Psychiatry, 26(6), 2056-2069. Nature Publishing Group
We conducted genome-wide association studies (GWAS) of relative intake from the macronutrients fat, protein, carbohydrates, and sugar in over 235,000 individuals of European ancestries. We identified 21 unique, approximately independent lead SNPs. Fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d8d05f37a3c2c398c885bc70c40da9
https://www.nature.com/articles/s41380-020-0697-5
https://www.nature.com/articles/s41380-020-0697-5
Autor:
Femke Rutters, Femmie de Vegt, Nicolaas C. Schaper, Coen D.A. Stehouwer, Harold W. de Valk, Bianca Silvius, Melanie M. van der Klauw, Sarah E. Siegelaar, Bastiaan E. de Galan, Bruce H. R. Wolffenbuttel, C.J.J. Tack, Evertine J. Abbink, Behiye Özcan, Eric J.G. Sijbrands, Petra J. M. Elders, Lian A. van Meijel, J. Hans DeVries, Miranda T. Schram
Publikováno v:
Van Meijel, L A, De Vegt, F, Abbink, E J, Rutters, F, Schram, M T, Van Der Klauw, M M, Wolffenbuttel, B H R, Siegelaar, S, Devries, J H, Sijbrands, E J G, Özcan, B, De Valk, H W, Silvius, B, Schaper, N, Stehouwer, C D A, Elders, P J M, Tack, C J & De Galan, B E 2020, ' High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes : The Dutch Diabetes Pearl Cohort ', BMJ Open Diabetes Research and Care, vol. 8, no. 1, e000935 . https://doi.org/10.1136/bmjdrc-2019-000935
BMJ open diabetes research and care, 8(1):e000935. BMJ Publishing Group
BMJ Open Diabetes Research and Care, 8(1):e000935
BMJ Open Diabetes Research & Care, 8(1):000935. BMJ PUBLISHING GROUP
BMJ Open Diabetes Research and Care, 8. BMJ Publishing Group
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, 8
BMJ Open Diabetes Research & Care, 8(1):000935. BMJ Publishing Group
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
BMJ Open Diabetes Research & Care, 8, 1
BMJ open diabetes research and care, 8(1):e000935. BMJ Publishing Group
BMJ Open Diabetes Research and Care, 8(1):e000935
BMJ Open Diabetes Research & Care, 8(1):000935. BMJ PUBLISHING GROUP
BMJ Open Diabetes Research and Care, 8. BMJ Publishing Group
BMJ Open Diabetes Research & Care
BMJ Open Diabetes Research & Care, 8
BMJ Open Diabetes Research & Care, 8(1):000935. BMJ Publishing Group
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
BMJ Open Diabetes Research & Care, 8, 1
ObjectivePeople with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemia can cause impaired awareness of hypoglycemia (IAH), and increase the risk for severe hypoglycemia. The aim of this study was to assess the prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::114a7cb66b1a54a31c6dc53f75f6d1bf
https://research.vumc.nl/en/publications/015f2dc9-776c-42a5-9409-4cbcc3fb4158
https://research.vumc.nl/en/publications/015f2dc9-776c-42a5-9409-4cbcc3fb4158
Autor:
Vincent W. Bloks, Ana B. Crujeiras, Eliza Fraszczyk, Mirjam Luijten, Jan Greve, Sander S. Rensen, Paul F.K. Wackers, Annemieke M.W. Spijkerman, Wim A. Buurman, Harold Snieder, Jana V. van Vliet-Ostaptchouk, Carla Barbosa Nonino, Carolina Ferreira Nicoletti, Bruce H. R. Wolffenbuttel
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Clinical Epigenetics
Clinical epigenetics, 12(1):14. BioMed Central Ltd
Clinical Epigenetics, 12(1):14. BMC
Universidade de São Paulo (USP)
instacron:USP
Clinical Epigenetics
Clinical epigenetics, 12(1):14. BioMed Central Ltd
Clinical Epigenetics, 12(1):14. BMC
Background Severe obesity is a growing, worldwide burden and conventional therapies including radical change of diet and/or increased physical activity have limited results. Bariatric surgery has been proposed as an alternative therapy showing promis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18758fd625e0c55359ce138d0b7d7654
Autor:
Robert G J Moes, Samuel J. P. Malkin, Tom Vandebrouck, Eline L. Huisman, Bruce H. R. Wolffenbuttel, Barnaby Hunt
Publikováno v:
BMJ Open Diabetes Research & Care, 7(1):000705. BMJ PUBLISHING GROUP
ObjectiveChoosing therapies for type 2 diabetes that are both effective and cost-effective is vital as healthcare systems worldwide aim to maximize health of the population. The present analysis assessed the cost-effectiveness of once-weekly semaglut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38357298b22003152d79671c39b11cc
https://research.rug.nl/en/publications/aeecdf30-6d65-41cf-8b5e-896b7d20af61
https://research.rug.nl/en/publications/aeecdf30-6d65-41cf-8b5e-896b7d20af61
Autor:
Harold Snieder, Jana V. van Vliet-Ostaptchouk, Helen L. Lutgers, Annemieke M.W. Spijkerman, Bruce H. R. Wolffenbuttel, Marc Jan Bonder, Mirjam Luijten, Eliza Walaszczyk
Publikováno v:
Diabetologia
Aims/hypothesis Epigenetic mechanisms may play an important role in the aetiology of type 2 diabetes. Recent epigenome-wide association studies (EWASs) identified several DNA methylation markers associated with type 2 diabetes, fasting glucose and Hb
Publikováno v:
Journal of Medical Economics, 19(12), 1167-1174. Taylor & Francis Ltd
Objective: To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro three times daily (TID) as add-on therapy when glycemic control is sub-optimal with titrated basal insulin glargine and metformin.Methods: The analys